Found: 59
Select item for more details and to access through your institution.
Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0208028
- By:
- Publication type:
- Article
Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 5, p. 777, doi. 10.1093/cid/ciy1003
- By:
- Publication type:
- Article
The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 5, p. 786, doi. 10.1093/cid/ciy1004
- By:
- Publication type:
- Article
Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
- Published in:
- Archives of Virology, 2010, v. 155, n. 9, p. 1391, doi. 10.1007/s00705-010-0719-8
- By:
- Publication type:
- Article
Consciousness: effect of coaching process and specifics through AI usage.
- Published in:
- e-mentor, 2020, v. 86, n. 4, p. 79, doi. 10.15219/em86.1485
- By:
- Publication type:
- Article
Development of Cross-Reactive Live Attenuated Influenza Vaccine Candidates against Both Lineages of Influenza B Virus.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 95, doi. 10.3390/vaccines12010095
- By:
- Publication type:
- Article
Overview of Nucleocapsid-Targeting Vaccines against COVID-19.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1810, doi. 10.3390/vaccines11121810
- By:
- Publication type:
- Article
Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1747, doi. 10.3390/vaccines11121747
- By:
- Publication type:
- Article
Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 501, doi. 10.3390/vaccines11030501
- By:
- Publication type:
- Article
In Vitro Stimulation with Live SARS-CoV-2 Suggests Th17 Dominance In Virus-Specific CD4+ T Cell Response after COVID-19.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1544, doi. 10.3390/vaccines10091544
- By:
- Publication type:
- Article
Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071142
- By:
- Publication type:
- Article
Understanding the Variability of Certain Biological Properties of H1N1pdm09 Influenza Viruses.
- Published in:
- Vaccines, 2022, v. 10, n. 3, p. 395, doi. 10.3390/vaccines10030395
- By:
- Publication type:
- Article
Development of a Novel Live Attenuated Influenza A Virus Vaccine Encoding the IgA-Inducing Protein.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 703, doi. 10.3390/vaccines9070703
- By:
- Publication type:
- Article
Anti-Influenza Effect of Nanosilver in a Mouse Model.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 679, doi. 10.3390/vaccines8040679
- By:
- Publication type:
- Article
Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 648, doi. 10.3390/vaccines8040648
- By:
- Publication type:
- Article
A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 296, doi. 10.3390/vaccines8020296
- By:
- Publication type:
- Article
Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 197, doi. 10.3390/vaccines8020197
- By:
- Publication type:
- Article
Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T Cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T Cell Responses and Protect Mice against both Infections.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 196, doi. 10.3390/vaccines8020196
- By:
- Publication type:
- Article
Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge.
- Published in:
- Vaccines, 2019, v. 7, n. 3, p. 61, doi. 10.3390/vaccines7030061
- By:
- Publication type:
- Article
Two Live Attenuated Vaccines against Recent Low–and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets.
- Published in:
- Vaccines, 2018, v. 6, n. 4, p. 74, doi. 10.3390/vaccines6040074
- By:
- Publication type:
- Article
The Effect of Mice Adaptation Process on the Pathogenicity of Influenza A/South Africa/3626/2013 (H1N1)pdm09 Model Strain.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 24, p. 17386, doi. 10.3390/ijms242417386
- By:
- Publication type:
- Article
Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides.
- Published in:
- Virology: Research & Treatment, 2017, v. 8, p. 1, doi. 10.1177/1178122X17710949
- By:
- Publication type:
- Article
A novel immunofluorescent test system for SARS-CoV-2 detection in infected cells.
- Published in:
- PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0304534
- By:
- Publication type:
- Article
Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/9359276
- By:
- Publication type:
- Article
Animal cloning and the FDA—the risk assessment paradigm under public scrutiny.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0102339
- By:
- Publication type:
- Article
Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087962
- By:
- Publication type:
- Article
REGULATIONS FOR THE BIOECONOMY.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus.
- Published in:
- Pathogens, 2020, v. 9, n. 6, p. 481, doi. 10.3390/pathogens9060481
- By:
- Publication type:
- Article
Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model.
- Published in:
- Microorganisms, 2021, v. 9, n. 2, p. 259, doi. 10.3390/microorganisms9020259
- By:
- Publication type:
- Article
COVID-19 in Light of Seasonal Respiratory Infections.
- Published in:
- Biology (2079-7737), 2020, v. 9, n. 9, p. 240, doi. 10.3390/biology9090240
- By:
- Publication type:
- Article
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.
- Published in:
- Virology Journal, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12985-024-02350-w
- By:
- Publication type:
- Article
Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets.
- Published in:
- BioMed Research International, 2018, v. 2018, p. 1, doi. 10.1155/2018/9695628
- By:
- Publication type:
- Article
Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83704-0
- By:
- Publication type:
- Article
M2e-based universal influenza vaccines: a historical overview and new approaches to development.
- Published in:
- Journal of Biomedical Science, 2019, v. 26, n. 1, p. N.PAG, doi. 10.1186/s12929-019-0572-3
- By:
- Publication type:
- Article
Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic A/California/07/2009(H1N1) influenza in healthy volunteers.
- Published in:
- BMC Research Notes, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13104-015-1086-z
- By:
- Publication type:
- Article
Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0180497
- By:
- Publication type:
- Article
A Live Probiotic Vaccine Prototype Based on Conserved Influenza a Virus Antigens Protect Mice against Lethal Influenza Virus Infection.
- Published in:
- Biomedicines, 2021, v. 9, n. 11, p. 1515, doi. 10.3390/biomedicines9111515
- By:
- Publication type:
- Article
Expert opinion on the identification, risk assessment, and mitigation of microorganisms and parasites relevant to xenotransplantation products from pigs.
- Published in:
- Xenotransplantation, 2023, v. 30, n. 5, p. 1, doi. 10.1111/xen.12815
- By:
- Publication type:
- Article
Regulation of xenogeneic porcine pancreatic islets.
- Published in:
- Xenotransplantation, 2010, v. 17, n. 5, p. 329, doi. 10.1111/j.1399-3089.2010.00592.x
- By:
- Publication type:
- Article
RDE Treatment Prevents Non-Specific Detection of SARS-CoV-2- and Influenza-Specific IgG Antibodies in Heat-Inactivated Serum Samples.
- Published in:
- Antibodies (2073-4468), 2023, v. 12, n. 2, p. 39, doi. 10.3390/antib12020039
- By:
- Publication type:
- Article
Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines.
- Published in:
- Antibodies (2073-4468), 2020, v. 9, n. 2, p. 20, doi. 10.3390/antib9020020
- By:
- Publication type:
- Article
Development of live cultural pandemic influenza vaccine Vector-Flu.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
A Strategy to Elicit M2e-Specific Antibodies Using a Recombinant H7N9 Live Attenuated Influenza Vaccine Expressing Multiple M2e Tandem Repeats.
- Published in:
- Biomedicines, 2021, v. 9, n. 2, p. 133, doi. 10.3390/biomedicines9020133
- By:
- Publication type:
- Article
Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
- Published in:
- Influenza & Other Respiratory Viruses, 2012, v. 6, n. 3, p. 188, doi. 10.1111/j.1750-2659.2011.00291.x
- By:
- Publication type:
- Article
B- and T-cell memory elicited by a seasonal live attenuated reassortant influenza vaccine: assessment of local antibody avidity and virus-specific memory T-cells using trogocytosis-based method.
- Published in:
- Influenza & Other Respiratory Viruses, 2012, v. 6, n. 2, p. 119, doi. 10.1111/j.1750-2659.2011.00279.x
- By:
- Publication type:
- Article
Phenotypic characteristics of novel swine-origin influenza A/California/07/2009 (H1N1) virus.
- Published in:
- Influenza & Other Respiratory Viruses, 2010, v. 4, n. 1, p. 1, doi. 10.1111/j.1750-2659.2009.00118.x
- By:
- Publication type:
- Article
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials).
- Published in:
- Influenza & Other Respiratory Viruses, 2008, v. 2, n. 6, p. 193, doi. 10.1111/j.1750-2659.2008.00064.x
- By:
- Publication type:
- Article
Immunization with live influenza viruses in an experimental model of allergic bronchial asthma: infection and vaccination.
- Published in:
- Influenza & Other Respiratory Viruses, 2008, v. 2, n. 5, p. 165, doi. 10.1111/j.1750-2659.2008.00061.x
- By:
- Publication type:
- Article
Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 1, p. 230, doi. 10.3390/v15010230
- By:
- Publication type:
- Article